The first vaccine against the Wuhan virus was developed by a German biotech company, BioNTech, in partnership with American pharmaceutical giant Pfizer.
So why is the vaccination rate in Germany stuck at 4% while the American vaccination rate is now quadruple that? Throughout Europe, it’s much the same story. The vaccination rate is 4% in France, Spain, Sweden and Italy, and 5% in Finland, Greece, Poland and Norway.
Only the UK, now separate from the EU, is doing well with a vaccination rate of 27% after approving the vaccine weeks before the FDA did in the U.S. (with the same data that the FDA ultimately based its approval on, it should be noted).
Unsurprisingly, this dawdling on the Continent has an effect: death. While the death rates have come down from January’s peak wave, daily new cases and daily deaths in the EU remain stubbornly high. In contrast, in the UK where the vaccine is really rolling, daily new cases are down by three-quarters and daily deaths are down two-thirds.